Madden Securities Corp Abb Vie Inc. Transaction History

Madden Securities Corp

$237 Million
Q4 2024

A detailed history of Madden Securities Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Madden Securities Corp holds 11,855 shares of ABBV stock, worth $2.18 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

11,855

Previous 12,330 3.85%

Holding current value

$2.18 Million

Previous $2.43 Million 13.48%

% of portfolio

0.89%

Previous 1.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$164.99 - $203.87 $78,370 - $96,838	-475 Reduced 3.85%	11,855 $2.11 Million
Q3 2024 Oct 09, 2024	SELL	$163.84 - $199.33 $74,547 - $90,695	-455 Reduced 3.56%	12,330 $2.43 Million
Q2 2024 Jul 10, 2024	SELL	$154.79 - $180.76 $4,643 - $5,422	-30 Reduced 0.23%	12,785 $2.19 Million
Q1 2024 Apr 09, 2024	SELL	$159.82 - $182.1 $34,361 - $39,151	-215 Reduced 1.65%	12,815 $2.33 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $172,412 - $194,177	-1,253 Reduced 8.77%	13,030 $2.02 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $16,030 - $18,558	-120 Reduced 0.83%	14,283 $2.13 Million
Q2 2023 Jul 06, 2023	BUY	$132.51 - $164.9 $13,648 - $16,984	103 Added 0.72%	14,403 $1.94 Million
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $23,716 - $27,312	-164 Reduced 1.13%	14,300 $2.28 Million
Q4 2022 Jan 10, 2023	SELL	$138.31 - $165.87 $186,856 - $224,090	-1,351 Reduced 8.54%	14,464 $0
Q3 2022 Oct 13, 2022	SELL	$134.21 - $153.93 $12,884 - $14,777	-96 Reduced 0.6%	15,815 $2.12 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $3.28 Million - $4.17 Million	-23,859 Reduced 59.99%	15,911 $2.44 Million
Q1 2022 Apr 28, 2022	SELL	$131.98 - $163.75 $143,990 - $178,651	-1,091 Reduced 2.67%	39,770 $6.45 Million
Q4 2021 Jan 14, 2022	BUY	$107.43 - $135.93 $97,224 - $123,016	905 Added 2.26%	40,861 $5.53 Million
Q3 2021 Oct 14, 2021	BUY	$106.4 - $120.78 $985,796 - $1.12 Million	9,265 Added 30.19%	39,956 $4.31 Million
Q2 2021 Jul 14, 2021	BUY	$105.21 - $117.21 $3,156 - $3,516	30 Added 0.1%	30,691 $3.46 Million
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $500,349 - $550,824	4,891 Added 18.98%	30,661 $3.32 Million
Q4 2020 Jan 12, 2021	BUY	$80.49 - $108.67 $154,782 - $208,972	1,923 Added 8.06%	25,770 $2.76 Million
Q3 2020 Oct 08, 2020	BUY	$85.91 - $100.83 $457,384 - $536,818	5,324 Added 28.74%	23,847 $2.09 Million
Q2 2020 Jul 14, 2020	BUY	$73.37 - $98.18 $896,067 - $1.2 Million	12,213 Added 193.55%	18,523 $1.82 Million
Q4 2019 Feb 25, 2020	BUY	$72.13 - $90.25 $455,140 - $569,477	6,310 New	6,310 $559,000

Others Institutions Holding ABBV

# of Institutions

3,891

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $325B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Madden Securities Corp, based on Form 13F filings with the SEC.

News

Stay updated on Madden Securities Corp with notifications on news.

Account

Madden Securities Corp Abb Vie Inc. Transaction History